PALO ALTO, Calif., Nov. 4 /PRNewswire/ -- Cell Biosciences, Inc., a provider of protein detection and characterization systems to life science researchers, today announced the launch of its first assay kits for the Firefly 3000(TM) Protein Analysis System. The Firefly 3000 is an ultrasensitive nano-immunoassay system that quantifies the phosphorylation of signaling proteins in samples as small as 25 cells.
The new Firefly 3000 Focusing Kits, Detection Kits, and Plate Kits were designed to provide highly reproducible analytical results in a convenient and flexible format. The kits are available with multiple separation ranges and multiple detection antibodies to address a wide range of assay requirements and workflows.
“I am pleased to announce the release of our first assay kits,” said Wilhelm Lachnit, Ph.D., Vice President of Research and Development. “We are committed to providing innovative whole-product solutions to our customers, and these kits represent a significant step toward that goal.”
About Cell Biosciences
Cell Biosciences is a private life sciences company focused on nano-proteomics. We develop instrumentation systems to enable the detection and characterization of specific proteins in extremely small biological samples. Our company’s lead product, the Firefly 3000, is a capillary-based nanofluidic immunoassay platform that provides quantitative and reproducible data on key signaling pathways while conserving precious biological samples. Cell Biosciences is located in Palo Alto, CA. http://www.cellbiosciences.com
For additional information, please contact Walter Ausserer, Ph.D., Vice President of Marketing, Cell Biosciences, Inc. 650 859-1485
CONTACT: Walter Ausserer, Ph.D., Vice President of Marketing of Cell
Biosciences, Inc., +1-650-859-1485
Web site: http://www.cellbiosciences.com/
